Non-coding RNAs in renal cell carcinoma: Implications for drug resistance

被引：6

作者：

Liu, Yiqi ^{[1
]}

Zhang, Hu ^{[2
]}

Fang, Yuan ^{[3
]}

Tang, Dongshan ^{[4
]}

Luo, Zhigang ^{[5
]}

机构：

[1] Univ South China, Hengyang Med Sch, Hengyang 421001, Hunan, Peoples R China

[2] Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Urol, Hengyang 421001, Hunan, Peoples R China

[3] Kunming Med Univ, Affiliated Hosp 1, Organ Transplantat Ctr, Kunming 650032, Yunnan, Peoples R China

[4] Univ South China, Sch Resources & Environm & Safety Engn, Hengyang 421001, Hunan, Peoples R China

[5] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Hengyang 421001, Hunan, Peoples R China

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2023年 / 164卷

关键词：

Renal cell carcinoma; Drug resistance; Non -coding RNAs; Biomarkers; MiRNAs; SUNITINIB RESISTANCE; TUMOR PROGRESSION; CIRCULAR RNAS; BREAST-CANCER; TUMORIGENESIS; CHEMORESISTANCE; TRANSCRIPTION; ANGIOGENESIS; METASTASIS; INHIBITION;

D O I：

10.1016/j.biopha.2023.115001

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Renal cell carcinoma (RCC) represents a malignant tumor of the urinary system. Individuals with early-stage RCC could be cured by surgical treatment, but a considerable number of cases of advanced RCC progress to drug resistance. Recently, numerous reports have demonstrated that a variety of non-coding RNAs (ncRNAs) contribute to tumor occurrence and development. ncRNAs can act as oncogenic or tumor suppressor genes to regulate proliferation, migration, drug resistance and other processes in RCC cells through a variety of signaling pathways. Considering the lack of treatment options for advanced RCC after drug resistance, ncRNAs may be a good choice as biomarkers of drug resistance in RCC and targets to overcome drug resistance. In this review, we discussed the effects of ncRNAs on drug resistance in RCC and the great potential of ncRNAs as a biomarker of or a new therapeutic method in RCC.

引用

页数：10

共 50 条

[31] Mitochondria-associated non-coding RNAs and their impact on drug resistance
An, Xingna
Sun, Lina
Zheng, Huan
Xiao, Yinghui
Sun, Weixia
Yu, Dehai
FRONTIERS IN PHARMACOLOGY, 2025, 16
[32] Long non-coding RNAs in anti-cancer drug resistance
Chen, Qin-nan
Wei, Chen-chen
Wang, Zhao-xia
Sun, Ming
ONCOTARGET, 2017, 8 (01) : 1925 - 1936
[33] Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Wang, Hongquan
Fleishman, Joshua S.
Cheng, Sihang
Wang, Weixue
Wu, Fan
Wang, Yumin
Wang, Yu
MOLECULAR CANCER, 2024, 23 (01)
[34] The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance
Lampropoulou, Dimitra Ioanna
Pliakou, Evangelia
Aravantinos, Gerasimos
Filippou, Dimitrios
Gazouli, Maria
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
[35] Implications of long non-coding RNAs (lncRNAs) in the treatment of oral squamous cell carcinoma (OSCC)
Sekar, Durairaj
ORAL ONCOLOGY, 2022, 127
[36] Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
Lai, Yongting
Feng, Bing
Abudoureyimu, Mubalake
Zhi, Yingru
Zhou, Hao
Wang, Ting
Chu, Xiaoyuan
Chen, Ping
Wang, Rui
FRONTIERS IN ONCOLOGY, 2019, 9
[37] Identification of unique long non-coding RNAs as putative biomarkers for chromophobe renal cell carcinoma
Wu, Guanlin
Xia, Pengfei
Yan, Shixian
Chen, Dongming
Xie, Lei
Fan, Gang
PERSONALIZED MEDICINE, 2021, 18 (01) : 9 - 19
[38] A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma
Cheng, Gong
Liu, Di
Liang, Huageng
Yang, Hongmei
Chen, Ke
Zhang, Xiaoping
AGING-US, 2019, 11 (21): : 9597 - 9615
[39] Long Non-Coding RNAs: A Double-Edged Sword in Renal Cell Carcinoma Carcinogenesis
Liu, Tian
Zhao, Hui
INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2022, 18 (08) : 1537 - 1549
[40] Implications of non-coding RNAs in viral infections
Sharma, Nikhil
Singh, Sunit K.
REVIEWS IN MEDICAL VIROLOGY, 2016, 26 (05) : 356 - 368

← 1 2 3 4 5 →